Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Biological sex influences antibody responses to routine vaccinations in the first year of life.

Zimmermann P, Perrett KP, Ritz N, Flanagan KL, Robins-Browne R, van der Klis FRM, Curtis N; MIS BAIR group.

Acta Paediatr. 2019 Jul 10. doi: 10.1111/apa.14932. [Epub ahead of print]

PMID:
31610635
2.

Does rotavirus turn on type 1 diabetes?

Harrison LC, Perrett KP, Jachno K, Nolan TM, Honeyman MC.

PLoS Pathog. 2019 Oct 10;15(10):e1007965. doi: 10.1371/journal.ppat.1007965. eCollection 2019 Oct. No abstract available.

3.

The Effect of Maternal Immunisation During Pregnancy on Infant Vaccine Responses.

Zimmermann P, Perrett KP, Messina NL, Donath S, Ritz N, van der Klis FRM, Curtis N.

EClinicalMedicine. 2019 Jul 26;13:21-30. doi: 10.1016/j.eclinm.2019.06.010. eCollection 2019 Aug.

4.

Earlier ingestion of peanut after changes to infant feeding guidelines: The EarlyNuts study.

Soriano VX, Peters RL, Ponsonby AL, Dharmage SC, Perrett KP, Field MJ, Knox A, Tey D, Odoi S, Gell G, Camesella Perez B, Allen KJ, Gurrin LC, Koplin JJ.

J Allergy Clin Immunol. 2019 Aug 8. pii: S0091-6749(19)31028-0. doi: 10.1016/j.jaci.2019.07.032. [Epub ahead of print]

PMID:
31401287
5.

Coding Error in Study of Rotavirus Vaccination and Type 1 Diabetes in Children.

Perrett KP, Jachno K, Nolan TM, Harrison LC.

JAMA Pediatr. 2019 Jul 15. doi: 10.1001/jamapediatrics.2019.2463. [Epub ahead of print] No abstract available.

PMID:
31305930
6.

Role of Rotavirus Vaccination in Decline in Incidence of Type 1 Diabetes-Reply.

Perrett KP, Jachno K, Nolan TM.

JAMA Pediatr. 2019 Jul 15. doi: 10.1001/jamapediatrics.2019.2460. [Epub ahead of print] No abstract available.

PMID:
31305870
7.

The influence of neonatal Bacille Calmette-Guérin (BCG) immunisation on heterologous vaccine responses in infants.

Zimmermann P, Donath S, Perrett KP, Messina NL, Ritz N, Netea MG, Flanagan KL, van der Klis FRM, Curtis N; MIS BAIR group.

Vaccine. 2019 Jun 19;37(28):3735-3744. doi: 10.1016/j.vaccine.2019.03.016. Epub 2019 May 29.

PMID:
31153688
8.

Influenza and pertussis vaccination of women during pregnancy in Victoria, 2015-2017.

Rowe SL, Perrett KP, Morey R, Stephens N, Cowie BC, Nolan TM, Leder K, Pitcher H, Sutton B, Cheng AC.

Med J Aust. 2019 Jun;210(10):454-462. doi: 10.5694/mja2.50125. Epub 2019 Apr 21.

PMID:
31006130
9.

Subcutaneous nodules: an important adverse event following immunization.

Silcock R, Crawford NW, Perrett KP.

Expert Rev Vaccines. 2019 Apr;18(4):405-410. doi: 10.1080/14760584.2019.1586540. Epub 2019 Mar 11.

PMID:
30808246
10.

Persistence of pneumococcal antibodies after primary immunisation with a polysaccharide-protein conjugate vaccine.

Zimmermann P, Perrett KP, Berbers G, Curtis N.

Arch Dis Child. 2019 Jul;104(7):680-684. doi: 10.1136/archdischild-2018-316254. Epub 2019 Feb 22.

PMID:
30796020
11.

The immunomodulatory effects of measles-mumps-rubella vaccination on persistence of heterologous vaccine responses.

Zimmermann P, Perrett KP, van der Klis FR, Curtis N.

Immunol Cell Biol. 2019 Jul;97(6):577-585. doi: 10.1111/imcb.12246. Epub 2019 Mar 28.

PMID:
30791143
12.

Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine.

Nolan T, Santolaya ME, de Looze F, Marshall H, Richmond P, Henein S, Rheault P, Heaton K, Perrett KP, Garfield H, Gupta A, Ferguson M, D'Agostino D, Toneatto D, O'Ryan M.

Vaccine. 2019 Feb 21;37(9):1209-1218. doi: 10.1016/j.vaccine.2018.12.059. Epub 2019 Jan 26.

13.

Vaccine Allergy? Skin Testing and Challenge at a Tertiary Pediatric Hospital in Melbourne, Australia.

Cheung A, Choo S, Perrett KP.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1541-1549. doi: 10.1016/j.jaip.2019.01.025. Epub 2019 Jan 23.

PMID:
30682574
14.

Association of Rotavirus Vaccination With the Incidence of Type 1 Diabetes in Children.

Perrett KP, Jachno K, Nolan TM, Harrison LC.

JAMA Pediatr. 2019 Mar 1;173(3):280-282. doi: 10.1001/jamapediatrics.2018.4578. No abstract available. Erratum in: JAMA Pediatr. 2019 Jul 15;:.

PMID:
30667473
15.

Diagnosing Peanut Allergy with Fewer Oral Food Challenges.

Koplin JJ, Perrett KP, Sampson HA.

J Allergy Clin Immunol Pract. 2019 Feb;7(2):375-380. doi: 10.1016/j.jaip.2018.11.010. Epub 2018 Dec 21. Review.

PMID:
30581130
16.

The Safety of Influenza and Pertussis Vaccination in Pregnancy in a Cohort of Australian Mother-Infant Pairs, 2012-2015: The FluMum Study.

McHugh L, Marshall HS, Perrett KP, Nolan T, Wood N, Lambert SB, Richmond P, Ware RS, Binks P, Binks MJ, Andrews RM.

Clin Infect Dis. 2019 Jan 18;68(3):402-408. doi: 10.1093/cid/ciy517.

PMID:
30475988
17.

Recurrence risk of a hypotonic hyporesponsive episode in two Australian specialist immunisation clinics.

Crawford NW, McMinn A, Royle J, Lazzaro T, Danchin M, Perrett KP, Buttery J, Elia S, Orr K, Wood N.

Vaccine. 2018 Oct 1;36(41):6152-6157. doi: 10.1016/j.vaccine.2018.08.062. Epub 2018 Sep 6.

PMID:
30197281
18.

Immunizations under sedation at a paediatric hospital in Melbourne, Australia from 2012-2016.

Cheng DR, Elia S, Perrett KP.

Vaccine. 2018 Jun 14;36(25):3681-3685. doi: 10.1016/j.vaccine.2018.05.018. Epub 2018 May 9.

PMID:
29753606
19.

Potential immediate hypersensitivity reactions following immunization in preschool aged children in Victoria, Australia.

Baxter CM, Clothier HJ, Perrett KP.

Hum Vaccin Immunother. 2018;14(8):2088-2092. doi: 10.1080/21645515.2018.1460293. Epub 2018 May 10.

20.

Time to Open Our Eyes? A Challenge to the Role of Polysomnography for Trials in Pediatric Sleep-Disordered Breathing.

Nixon GM, Kubba H, Perrett KP.

J Clin Sleep Med. 2018 Mar 15;14(3):489-490. doi: 10.5664/jcsm.7014. No abstract available.

21.

Immunogenicity and safety of one or two doses of the quadrivalent meningococcal vaccine MenACWY-TT given alone or with the 13-valent pneumococcal conjugate vaccine in toddlers: A phase III, open-label, randomised study.

Cutland CL, Nolan T, Halperin SA, Kurugol Z, Ahmed K, Perrett KP, Richmond P, Marshall HS, Ceyhan M, Kolhe D, Hezareh M, Van Der Wielen M.

Vaccine. 2018 Mar 27;36(14):1908-1916. doi: 10.1016/j.vaccine.2018.02.013. Epub 2018 Mar 2.

22.

Vaccine decision-making begins in pregnancy: Correlation between vaccine concerns, intentions and maternal vaccination with subsequent childhood vaccine uptake.

Danchin MH, Costa-Pinto J, Attwell K, Willaby H, Wiley K, Hoq M, Leask J, Perrett KP, O'Keefe J, Giles ML, Marshall H.

Vaccine. 2018 Oct 22;36(44):6473-6479. doi: 10.1016/j.vaccine.2017.08.003. Epub 2017 Aug 12.

PMID:
28811050
23.

Immunization During Pregnancy: Impact on the Infant.

Perrett KP, Nolan TM.

Paediatr Drugs. 2017 Aug;19(4):313-324. doi: 10.1007/s40272-017-0231-7. Review.

PMID:
28510067
24.

Birth outcomes for Australian mother-infant pairs who received an influenza vaccine during pregnancy, 2012-2014: The FluMum study.

McHugh L, Andrews RM, Lambert SB, Viney KA, Wood N, Perrett KP, Marshall HS, Richmond P, O'Grady KF.

Vaccine. 2017 Mar 7;35(10):1403-1409. doi: 10.1016/j.vaccine.2017.01.075. Epub 2017 Feb 9.

PMID:
28190746
25.

Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: a phase III, randomized, multicentre, lot-to-lot consistency study.

Perrett KP, McVernon J, Richmond PC, Marshall H, Nissen M, August A, Percell S, Toneatto D, Nolan T.

Vaccine. 2015 Sep 22;33(39):5217-24. doi: 10.1016/j.vaccine.2015.06.103. Epub 2015 Jul 29.

PMID:
26232542
27.

Antibody persistence in Australian adolescents following meningococcal C conjugate vaccination.

Perrett KP, Richmond PC, Borrow R, Nolan T, McVernon J.

Pediatr Infect Dis J. 2015 Mar;34(3):279-85. doi: 10.1097/INF.0000000000000541.

28.

Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013.

Cheng DR, Perrett KP, Choo S, Danchin M, Buttery JP, Crawford NW.

Vaccine. 2015 Mar 24;33(13):1602-7. doi: 10.1016/j.vaccine.2015.02.008. Epub 2015 Feb 16.

PMID:
25698493
29.

Long-term persistence of immunity and B-cell memory following Haemophilus influenzae type B conjugate vaccination in early childhood and response to booster.

Perrett KP, John TM, Jin C, Kibwana E, Yu LM, Curtis N, Pollard AJ.

Clin Infect Dis. 2014 Apr;58(7):949-59. doi: 10.1093/cid/ciu001. Epub 2014 Jan 7.

PMID:
24403544
30.

A Licensed Combined Haemophilus influenzae Type b-Serogroups C and Y Meningococcal Conjugate Vaccine.

Perrett KP, Nolan TM, McVernon J.

Infect Dis Ther. 2013 Jun;2(1):1-13. doi: 10.1007/s40121-013-0007-5. Epub 2013 Jun 5.

31.

B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody.

Perrett KP, Jin C, Clutterbuck E, John TM, Winter AP, Kibwana E, Yu LM, Curtis N, Pollard AJ.

J Immunol. 2012 Sep 1;189(5):2673-81. doi: 10.4049/jimmunol.1200451. Epub 2012 Aug 1.

32.

Single nucleotide polymorphisms in the Toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine.

Moore CE, Hennig BJ, Perrett KP, Hoe JC, Lee SJ, Fletcher H, Brocklebank D, O'Connor D, Snape MD, Hall AJ, Segal S, Hill AV, Pollard AJ.

Clin Vaccine Immunol. 2012 Mar;19(3):295-303. doi: 10.1128/CVI.05379-11. Epub 2011 Dec 28.

33.

Recurrent apnoea post immunisation: Informing re-immunisation policy.

Clifford V, Crawford NW, Royle J, Lazzaro T, Danchin M, Perrett KP, Lee KJ, Buttery JP.

Vaccine. 2011 Aug 5;29(34):5681-7. doi: 10.1016/j.vaccine.2011.06.005. Epub 2011 Jun 20.

PMID:
21693156
34.

Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999-2000 and response to a booster: a phase 4 clinical trial.

Perrett KP, Winter AP, Kibwana E, Jin C, John TM, Yu LM, Borrow R, Curtis N, Pollard AJ.

Clin Infect Dis. 2010 Jun 15;50(12):1601-10. doi: 10.1086/652765.

PMID:
20459323
35.

Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

Pollard AJ, Perrett KP, Beverley PC.

Nat Rev Immunol. 2009 Mar;9(3):213-20. doi: 10.1038/nri2494. Review.

PMID:
19214194
36.

Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants.

Perrett KP, Snape MD, Ford KJ, John TM, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, Anemona A, Halperin SA, Dobson S, Pollard AJ.

Pediatr Infect Dis J. 2009 Mar;28(3):186-93. doi: 10.1097/INF.0b013e31818e037d.

PMID:
19209097
37.

Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.

Kelly DF, Snape MD, Perrett KP, Clutterbuck EA, Lewis S, Blanchard Rohner G, Jones M, Yu LM, Pollard AJ.

Immunology. 2009 May;127(1):134-43. doi: 10.1111/j.1365-2567.2008.02934.x. Erratum in: Immunology. 2011 Apr;132(4):589.

38.

Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial.

Snape MD, Perrett KP, Ford KJ, John TM, Pace D, Yu LM, Langley JM, McNeil S, Dull PM, Ceddia F, Anemona A, Halperin SA, Dobson S, Pollard AJ.

JAMA. 2008 Jan 9;299(2):173-84. doi: 10.1001/jama.2007.29-c. Erratum in: JAMA. 2011 Mar 16;305(11):1096.

PMID:
18182599
39.

Towards an improved serogroup B Neisseria meningitidis vaccine.

Perrett KP, Pollard AJ.

Expert Opin Biol Ther. 2005 Dec;5(12):1611-25. Review.

PMID:
16318425

Supplemental Content

Loading ...
Support Center